AU2002239366A1 - Anti-angiogenic polypeptides - Google Patents

Anti-angiogenic polypeptides

Info

Publication number
AU2002239366A1
AU2002239366A1 AU2002239366A AU3936602A AU2002239366A1 AU 2002239366 A1 AU2002239366 A1 AU 2002239366A1 AU 2002239366 A AU2002239366 A AU 2002239366A AU 3936602 A AU3936602 A AU 3936602A AU 2002239366 A1 AU2002239366 A1 AU 2002239366A1
Authority
AU
Australia
Prior art keywords
seq
plasminogen
polypeptide
human
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002239366A
Other languages
English (en)
Inventor
Geetha Kassam
Mijung Kwon
David M. Waisman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002239366A1 publication Critical patent/AU2002239366A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
AU2002239366A 2000-11-28 2001-11-28 Anti-angiogenic polypeptides Abandoned AU2002239366A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25372500P 2000-11-28 2000-11-28
US60/253,725 2000-11-28
PCT/US2001/044515 WO2002044328A2 (fr) 2000-11-28 2001-11-28 Polypeptides anti-angiogeniques

Publications (1)

Publication Number Publication Date
AU2002239366A1 true AU2002239366A1 (en) 2002-06-11

Family

ID=22961462

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002239366A Abandoned AU2002239366A1 (en) 2000-11-28 2001-11-28 Anti-angiogenic polypeptides

Country Status (8)

Country Link
US (2) US7420036B2 (fr)
EP (1) EP1337548B1 (fr)
CN (1) CN100491394C (fr)
AT (1) ATE401337T1 (fr)
AU (1) AU2002239366A1 (fr)
CA (1) CA2426543C (fr)
DE (1) DE60134885D1 (fr)
WO (1) WO2002044328A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7420036B2 (en) 2000-11-28 2008-09-02 Waisman David M Anti-angiogenic polypeptides
US7250271B2 (en) 2001-11-28 2007-07-31 David Waisman Anti-angiogenesis methods, compositions and uses therefor
AU2003239368A1 (en) 2002-05-06 2003-11-17 Board Of Regents, The University Of Texas System Targeting proteins to deliver therapeutic or diagnostic reagents
WO2004054517A2 (fr) 2002-12-13 2004-07-01 Mediomics, Llc Compositions et methodes d'inhibition de la croissance des tumeurs et des metastases
WO2006075165A1 (fr) * 2005-01-13 2006-07-20 Btg International Limited Combinaison de virus oncolytiques a des inhibiteurs d'angiogenese
CN101219219B (zh) * 2007-01-10 2013-02-13 北京普罗吉生物科技发展有限公司 包含血管抑素或其片段的复合物、其制备方法及应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1194135B (it) * 1981-01-05 1988-09-14 Novo Industri As Composizioni di plasmina stabilizzata e metodo per la loro preparazione
AU647391B2 (en) 1989-05-01 1994-03-24 University Of Notre Dame Du Lac, The Methods and materials for expression of human plasminogen in a eukaryotic cell system
US5837682A (en) 1996-03-08 1998-11-17 The Children's Medical Center Corporation Angiostatin fragments and method of use
US5639725A (en) 1994-04-26 1997-06-17 Children's Hospital Medical Center Corp. Angiostatin protein
US5945403A (en) 1997-05-30 1999-08-31 The Children's Medical Center Corporation Angiostatin fragments and method of use
EP0910571B1 (fr) 1996-05-03 2005-07-20 Abbott Laboratories Nouveaux peptides anti-angiogeniques, polynucleotides les codant et procedes d'inhibition de l'angiogenese
US5801012A (en) 1996-09-17 1998-09-01 Northwestern University Methods and compositions for generating angiostatin
EP1001985A1 (fr) 1997-06-26 2000-05-24 Karolinska Innovations AB Domaines kringle 1-5 de plasminogene permettant de moduler l'angiogenese in vivo
ID27676A (id) * 1997-09-11 2001-04-19 Sony Corp Peralatan elektronik
AU9673998A (en) 1997-10-01 1999-04-23 G.D. Searle & Co. Fusion proteins comprising an angiostatin moiety and their use in anti-tumor treatment
DK1313504T3 (da) 2000-09-01 2007-02-26 Philadelphia Health & Educatio Fremgangsmåder og sammensætninger til hæmning af angiogenese
US7420036B2 (en) 2000-11-28 2008-09-02 Waisman David M Anti-angiogenic polypeptides

Also Published As

Publication number Publication date
US7420036B2 (en) 2008-09-02
ATE401337T1 (de) 2008-08-15
EP1337548B1 (fr) 2008-07-16
US20040082030A1 (en) 2004-04-29
US20090061510A1 (en) 2009-03-05
CN100491394C (zh) 2009-05-27
US7626008B2 (en) 2009-12-01
WO2002044328A2 (fr) 2002-06-06
CA2426543C (fr) 2007-09-18
EP1337548A2 (fr) 2003-08-27
CN1498223A (zh) 2004-05-19
CA2426543A1 (fr) 2002-06-06
DE60134885D1 (de) 2008-08-28
EP1337548A4 (fr) 2005-01-12
WO2002044328A3 (fr) 2003-04-03

Similar Documents

Publication Publication Date Title
AU2014210620B2 (en) Antidotes for factor XA inhibitors and methods of using the same
ES2605801T3 (es) Formulación de dosis unitaria de antídoto para inhibidores del factor Xa para su uso en la prevención de la hemorragia
ES2607935T3 (es) Antídotos para inhibidores del factor Xa y procedimientos de uso de los mismos
JP5558106B2 (ja) 凝固第ｖｉｉ因子関連ポリペプチドの皮下投与
US7626008B2 (en) Anti-angiogenic polypeptides
JP4986618B2 (ja) 通常の細胞保護活性を有するが抗凝固活性が低下した活性化プロテインｃ変異体
JP2010508031A (ja) 通常の細胞保護活性を有するが抗凝固活性が低下した活性化プロテインｃ変異体
US6833357B2 (en) Compositions and methods for modulating muscle cell and tissue contractility
US6365364B1 (en) Angiogenesis inhibitors and uses thereof
US20060099671A1 (en) Methods and compositions for generating angiostatin
Kwon Mechanism of Angiostatin Generation from Plasminogen